Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea.

Obstructive sleep apnea (OSA) is a common sleep disorder characterized by intermittent airway blockages during sleep, leading ...

For about 25 million Americans who suffer from obstructive sleep apnea, there are various effective treatments such as CPAP breathing machines, surgery, a dental mouthpiece and even an implantable pac ...

From sleep apnea-fighting mattresses to smart rings that play lullabies, the best sleep tech from Day 1 of CES 2025 ...

OSA impacts about 936 million people worldwide and occurs when the throat muscles relax and block the airway with a common ...

Background: The pathogenesis of daytime hypercapnia (PaCO 2 ≥ 45 mm Hg) may be directly linked to the existence of obstructive sleep apnea syndrome (OSAS) per se, although only some patients ...

The excessive daytime sleepiness market drowsiness was projected to be worth USD 4.9 billion in 2022. With an expected CAGR of 8.8% from 2023 to 2033, this market is expected to earn USD 5.33 billion ...

Explore daily insights on the USA TODAY crossword puzzle by . Uncover expert takes and answers in our crossword blog.

When I have sleep problems, it's usually not about struggling to fall asleep; I conk out pretty quickly once I get in bed.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Obese mice whose fat cells were genetically altered to produce an increased amount of the glucose-dependent insulinotropic ...